Protein transfer is a broad term covering every process by which proteins move from one location to another, whether inside a single cell, between neighboring cells, from mother to fetus, from a bacterium into its host, or from a gel onto a membrane in a research lab. The phrase shows up in immunology, cancer biology, neuroscience, microbiology, and everyday laboratory work, each time describing something mechanistically distinct. What ties these processes together is that proteins rarely stay where they are made, and the ways they travel determine everything from how a newborn fights infection to how a tumor resists chemotherapy.
Proteins on the Move Inside a Single Cell
Before proteins can be transferred between cells or organisms, they first need to get where they are going within the cell that made them. Most proteins are built by ribosomes in the main body of the cell, but many need to end up somewhere else entirely, like inside the nucleus or inside mitochondria. Each of these destinations has its own gatekeeper machinery.
Getting into the nucleus, for example, requires passage through nuclear pore complexes, massive channel structures studded across the nuclear envelope. Small molecules can drift through passively, but larger proteins need an escort. A protein called importin-beta latches onto cargo proteins that carry a specific signal tag, ferries them through the pore, and then releases them once inside the nucleus. The cycle is reset by a molecule called RanGTP, which binds importin-beta and kicks the cargo loose so the escort can head back out for another round.1PubMed Central. Dominant-negative mutants of importin-beta block multiple pathways of import and export through the nuclear pore complex
Mitochondria present a different challenge. These organelles have their own double membrane, so proteins destined for the mitochondrial interior must cross two barriers. A complex on the outer membrane called TOM (translocase of the outer membrane) recognizes incoming proteins by short signal sequences at their front end and threads them through. Once in the space between the two membranes, a second complex called TIM23 pulls them the rest of the way in.2PubMed Central. Structural overview of the translocase of the mitochondrial outer membrane complex The system is remarkably efficient considering that the vast majority of mitochondrial proteins are actually encoded by genes in the cell’s nucleus, not by the mitochondria’s own tiny genome.
Cell-to-Cell Transfer in the Immune System and Beyond
Protein transfer between cells is not just a laboratory curiosity. Your immune cells do it constantly. One of the more striking examples is trogocytosis, a process where one cell literally nibbles a piece of membrane off another living cell during direct contact. The transferred chunk carries surface proteins that remain functional on their new host. T cells, B cells, natural killer cells, and antigen-presenting cells all participate, swapping molecules that include receptors, signaling molecules, and identity markers.3PubMed Central. Gnawing Between Cells and Cells in the Immune System: Friend or Foe? A Review of Trogocytosis The result is that a cell can temporarily display proteins it never produced itself, which can alter its behavior and how other cells interact with it.
Cells also build physical bridges to each other. Tunneling nanotubes are thin membranous tubes, narrower than a micrometer, that stretch between distant cells and allow cargo to travel directly through a protected corridor. These tubes can shuttle not just proteins but entire organelles, including lysosomes, mitochondria, and Golgi bodies.4PubMed Central. Intercellular transport of Tau protein and β-amyloid mediated by tunneling nanotubes The nanotubes play roles in cell growth regulation, signal transmission, and, as we will see, disease progression.5ACS Nano. Intercellular Tunneling Nanotubes as Natural Biophotonic Conveyors
A third route for cell-to-cell protein transfer involves extracellular vesicles, tiny membrane-bound packages that cells release into their surroundings. Other cells can pick these up, absorbing the protein cargo inside. This mechanism is not limited to animal cells. Researchers have shown that vesicles derived from grapefruit can deliver functional exogenous proteins into human cells, including immune cells and colon cancer cells, and that the delivered proteins retain their activity.6PubMed Central. Delivery of functional exogenous proteins by plant-derived vesicles to human cells in vitro That finding opens the door to using plant-derived vesicles as delivery vehicles in medicine, a topic explored further below.
How Mothers Arm Their Newborns
One of the most consequential forms of protein transfer happens before birth. A newborn’s immune system cannot produce enough protective antibodies on its own during the first months of life, so the mother’s antibodies must cross the placenta to fill that gap. The workhorse here is a receptor called FcRn (the neonatal Fc receptor), which sits on the surface of placental cells and actively transports IgG antibodies from the mother’s blood into the fetal circulation.7PubMed Central. Factors Affecting the FcRn-Mediated Transplacental Transfer of Antibodies and Implications for Vaccination in Pregnancy Studies in genetically engineered mice have confirmed that FcRn, and not other antibody receptors, is the major driver of this transfer.8Proceedings of the National Academy of Sciences. FcRn, but not FcγRs, drives maternal-fetal transplacental transport of human IgG antibodies
The placenta is not a passive filter, though. It preferentially selects certain antibodies over others. Antibodies with specific sugar modifications on their tails are transferred more efficiently, while others are held back. This selective sieving appears to favor antibodies that are especially good at activating natural killer cells, essentially arming the newborn with the most useful part of the mother’s immune arsenal.9Cell. Selective Placental Transfer of Reactive Antibodies to Neonates Maternal vaccination during pregnancy exploits this pathway: the antibodies a mother generates against a pathogen cross the placenta and protect the baby for weeks to months after birth.
After birth, colostrum (the thick first milk produced in the days surrounding delivery) provides another round of antibody transfer. In infants who received colostrum, researchers observed significant increases in circulating IgG compared to those who did not, along with higher levels of other immunoglobulin classes. The findings suggest that immunoglobulins in colostrum are absorbed through the newborn’s intestinal tract, contributing to infection resistance during the vulnerable neonatal period.10PubMed Central. Intestinal absorption of immunoglobulins by newborn infants The molecular machinery behind this intestinal absorption involves pathways like clathrin-mediated endocytosis, and research in neonatal goats has shown that the timing of colostrum feeding significantly affects how much IgG the gut can absorb.11PubMed Central. Multi-omics analysis provides new insights into the molecular mechanisms underlying colostral immunoglobulin G absorption in the gut of neonatal goat kids
Bacteria That Inject Proteins Into Your Cells
Protein transfer is not always benign. Many disease-causing bacteria have evolved elaborate molecular syringes to shoot their own proteins directly into host cells. These are called secretion systems, and they come in several types, each with a different architecture and host target.12PubMed Central. Bacterial Secretion Systems: An Overview
The type III secretion system is one of the best studied. It functions like a molecular needle, assembling a structure that physically punctures the host cell membrane and injects effector proteins into the cytoplasm. Once inside, these effector proteins hijack the host cell’s signaling, suppress immune responses, rearrange the cell’s internal skeleton, or create a sheltered niche for the bacterium to replicate.13Science. Type III Secretion Machines: Bacterial Devices for Protein Delivery into Host Cells Pathogens that use this system include the bacteria responsible for food poisoning, dysentery, and plague. Understanding these delivery machines has also inspired bioengineers who want to borrow the concept for therapeutic protein delivery.
When Protein Transfer Drives Disease
In neurodegenerative disorders like Alzheimer’s and Parkinson’s disease, a growing body of evidence points to cell-to-cell transmission of misfolded proteins as a common mechanism for how the disease starts and spreads through the brain.14PubMed Central. Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases Tunneling nanotubes are one of the routes these harmful proteins can travel, with studies demonstrating that both tau protein and beta-amyloid, the two hallmarks of Alzheimer’s, move through these intercellular tunnels.15PubMed Central. Intercellular transport of Tau protein and β-amyloid mediated by tunneling nanotubes The implication is sobering: a small number of cells producing misfolded proteins can seed pathology across wide regions of the brain by passing those proteins to their neighbors.
Cancer exploits protein transfer in a different but equally troubling way. A key reason chemotherapy fails is that tumor cells develop drug-resistance pumps on their surface. One such pump, called P-glycoprotein, actively expels chemotherapy drugs from the cell. Researchers discovered that P-glycoprotein-positive tumor cells can pass functional copies of this pump to nearby cells that lack it, conferring drug resistance without any genetic change. The acquired resistance is temporary in isolated cells but persists as long as the donor cells remain nearby or the drug pressure continues, buying sensitive cells time to develop their own permanent resistance.16PubMed Central. Intercellular transfer of P-glycoprotein mediates acquired multidrug resistance in tumor cells
Exosomes add yet another layer. In non-small cell lung cancer, tumor cells that are not responsive to a targeted drug can package a specific receptor protein into exosomes and send those to drug-sensitive neighbor cells. When the sensitive cells absorb these exosomes, the delivered receptor activates signaling pathways that make them resistant to the drug as well. Blocking the exosomes or neutralizing the receptor protein with antibodies restores sensitivity, suggesting this transfer route could be a therapeutic target.17Molecular Cancer. Intercellular transfer of exosomal wild type EGFR triggers osimertinib resistance in non-small cell lung cancer
How Plants and Egg Cells Handle Protein Transfer
Plants face a unique challenge: their cells are surrounded by rigid walls, which makes the kind of membrane-nibbling and vesicle-swapping that animal cells use far more constrained. Instead, plant cells communicate through plasmodesmata, narrow channels that punch through the cell wall and directly connect the interiors of adjacent cells. These channels are not passive pipes. They actively regulate which proteins and other large molecules can pass, making them critical players in gene regulation and development.18PubMed Central. Cell-to-cell transport of proteins and fluorescent tracers via plasmodesmata during plant development Transcription factors that control cell fate, for instance, sometimes exert their effects by traveling through plasmodesmata into neighboring cells rather than acting only in the cell where they were made.
Egg-laying animals have their own specialized protein transfer system. In birds and amphibians, growing egg cells need massive quantities of yolk protein to support the developing embryo. The liver produces a precursor protein called vitellogenin, releases it into the bloodstream, and the ovary pulls it in. In quail, vitellogenin and other lipoproteins diffuse through spaces between the follicle cells surrounding the oocyte and then enter the oocyte via receptor-mediated endocytosis, being ferried inward through coated vesicles to form yolk.19Zoological Science. Vitellogenin Transport and Yolk Formation in the Quail Ovary A similar receptor-driven process operates in frogs, where vitellogenin moves from coated vesicles into endosomes through vesicle-to-vesicle fusion.20Development, Growth & Differentiation. In Vivo Study of Vitellogenin‐Gold Transport in the Ovarian Follicle and Oocyte of Xenopus laevis
Engineered Protein Delivery for Therapeutics
If cells have so many natural ways to move proteins, can we hijack or mimic those mechanisms to deliver therapeutic proteins into cells on purpose? That is one of the central questions in drug delivery research, and the answer is increasingly yes.
Cell-penetrating peptides are short chains of amino acids that can cross cell membranes without damaging them. Researchers have attached these peptides to all sorts of cargo, including nanoparticles, small drug molecules, and even DNA, and used them to smuggle those payloads into cells.21PubMed Central. Intracellular Delivery of Molecular Cargo Using Cell-Penetrating Peptides and the Combination Strategies One limitation of early cell-penetrating peptides was that blood serum proteins could interfere with delivery. A newer engineered peptide called eTAT overcomes this by combining multiple functional modules into a single chimeric molecule, and it has been shown to deliver proteins into cells efficiently even in the presence of full serum.22Nature Communications. Efficient intracellular delivery of proteins by a multifunctional chimaeric peptide in vitro and in vivo
Plant-derived vesicles represent another frontier. As mentioned earlier, grapefruit-derived extracellular vesicles can carry functional proteins into human cells, including immune cells and cancer cells.23PubMed Central. Delivery of functional exogenous proteins by plant-derived vesicles to human cells in vitro Because these vesicles come from edible plants and appear to be well tolerated, they could eventually serve as an inexpensive, scalable platform for delivering protein-based drugs or vaccines, though the research is still in early stages.
Protein Transfer in the Laboratory
For researchers, “protein transfer” most often means the step in a Western blot where proteins separated by size in a gel are moved onto a membrane so they can be probed with antibodies. The proteins migrate out of the gel under an electric field and stick to the membrane surface through hydrophobic interactions. The two most common membrane materials, PVDF and nitrocellulose, both bind proteins this way, though PVDF does so through hydrophobic and dipole interactions on its fluoropolymer surface, while nitrocellulose relies on hydrophobic interactions between the protein and its cellulose-nitrate matrix.24PubMed Central. Comparison of the sensitivity of Western blotting between PVDF and NC membranes Nitrocellulose binds proteins somewhat more weakly, which is why researchers sometimes use high salt concentrations to fix the proteins more tightly to the membrane.25PubMed. Mechanism of DNA (Southern) and protein (Western) blotting on cellulose nitrate and other membranes
One persistent headache in Western blotting is transferring very large proteins. High-molecular-weight proteins get tangled in the gel matrix and resist moving out, while small proteins can blow right through the membrane. A heated transfer method addresses both problems by running the transfer at 70 to 75 degrees Celsius using buffer without methanol. The heat loosens the gel structure, allowing large proteins to escape, and the methanol-free conditions prevent over-shrinkage of the gel. Complete transfer of both high and low molecular weight proteins from a standard thin gel can be achieved in as little as ten minutes, compared to hours with conventional cold-transfer protocols.26PubMed. Ultrarapid electrophoretic transfer of high and low molecular weight proteins using heat For thicker gels, the time extends to about twenty minutes but still represents a dramatic speedup.27PubMed Central. Western blotting of high and low molecular weight proteins using heat
The choice of membrane, buffer composition, and transfer conditions may sound like technical minutiae, but they directly affect whether a researcher can detect the protein they are looking for. A failed transfer means a failed experiment, which is why troubleshooting transfer efficiency is one of the most common conversations in any molecular biology lab. Understanding that the protein sticks to the membrane through hydrophobic forces, and that anything disrupting those forces (wrong buffer, wrong temperature, wrong membrane pore size) can ruin the result, gives researchers a framework for fixing problems rather than just guessing.